Prostate cancer researchers find genetic fingerprint identifying how, when disease spreads

January 9, 2017
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia

Canadian prostate cancer researchers have discovered the genetic fingerprint that explains why up to 30 per cent of men with potentially curable localized prostate cancer develop aggressive disease that spreads following radiotherapy or surgery.

The findings, published online today in Nature, could help clinicians personalize effective, targeted therapies from the moment of diagnosis, says co-principal investigator Robert Bristow, clinician-scientist at the Princess Margaret Cancer Centre, University Health Network. Dr. Bristow is also a Professor in the Departments of Radiation Oncology and Medical Biophysics, University of Toronto.

In the Nature study, Dr. Bristow, co-principal investigator Dr. Paul Boutros from the Ontario Institute for Cancer Research, lead author Dr. Michael Fraser, and collaborators at Laval University in Quebec City, analyzed the tumours of 500 Canadian men in the general population with localized, non-inherited prostate cancer. In a related study also published today, in Nature Communications, Drs. Bristow and Boutros cracked the genetic code to show why BRCA-2 inherited disease turns lethal in rare cases where men have inherited a BRCA2 gene mutation that affects the repair of DNA damage in cells.

"We used specialized state-of-the-art DNA sequencing techniques to focus on the genetics of prostate cancers to better understand what is so different from one man's disease to another man's disease," says Dr. Bristow.

"These genetic fingerprints had high accuracy in being able to discern those men who do well with surgery or radiotherapy and those men that already have early spread of their disease outside the prostate gland. This information gives us new precision about the treatment response of men with prostate cancer, and important clues as to how to better treat one set of men versus the other to improve cure rates overall."

The next step will be to translate this research finding into a molecular diagnostic tool that can be used in the clinic. Dr. Bristow says: "We will be testing 500 more men over the next two to three years to accomplish that. It is an exciting era in prostate cancer research. We will soon be able to identify in the clinic the exact genetic state of a man's cancer and react on a patient-to-patient basis to cure more men worldwide. "

The video will load shortly
Canadian prostate cancer researchers have discovered the genetic fingerprint that explains why up to 30 percent of men with potentially curable localized prostate cancer develop aggressive disease that spreads following radiotherapy or surgery. Credit: UHN

Drs. Bristow and Boutros co-lead the Canadian Prostate Cancer Genome Network (CPC-GENE), the world-leading prostate cancer sequencing program. The research published today builds on their previous published discoveries:

  • first molecular portrait of localized, multi-focal prostate cancer and a new gene subgroup driving it (Nature Genetics, May 25, 2015);
  • development of a genetic test to identify which men are at highest risk for their to recur after localized treatment with surgery or radiotherapy (Lancet Oncology, Nov 13, 2014).

Dr. Bristow says that although most men present with localized, potentially curable disease, more than 200,000 men die of it every year when tallied across all countries.

"The richness of information in our genetic findings today will enable us to further sort individual patients into appropriate groups of risk for spread of their disease and effect cures in men who otherwise might have been incurable."

Explore further: Researchers unveil new gene subgroup in prostate cancer

More information: Nature, nature.com/articles/doi:10.1038/nature20788
Nature Communications, nature.com/articles/doi:10.1038/ncomms13671

Related Stories

Researchers unveil new gene subgroup in prostate cancer

May 25, 2015
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.

Prostate cancer researchers develop personalized genetic test to predict recurrence risk

November 12, 2014
Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy.

Scientists find new gene tool for predicting course of prostate cancer

December 20, 2016
Researchers from UR Medicine's Wilmot Cancer Institute and Roswell Park Cancer Institute in Buffalo reported in the journal Oncotarget, they have discovered a possible new tool for predicting whether prostate cancer will ...

New test developed to detect men at high risk of prostate cancer recurrence

April 5, 2014
Vienna, Austria: A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference ...

Researchers pinpoint key regulatory role of noncoding genes in prostate cancer development

August 15, 2016
Prostate cancer researchers studying genetic variations have pinpointed 45 genes associated with disease development and progression.

Testing for inherited mutations could benefit men with advanced prostate cancer

July 6, 2016
Inherited mutations in genes that function to repair DNA may contribute to metastatic prostate cancer more than previously recognized, according to a study out today in the New England Journal of Medicine. Though infrequent ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.